Brinker Capital Investments’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.06M | Sell |
90,220
-9,854
| -10% | -$795K | 0.05% | 308 |
|
|
2026
Q1 | $8.67M | Sell |
100,074
-24,597
| -20% | -$2.36M | 0.07% | 229 |
|
|
2025
Q4 | $12M | Buy |
124,671
+3,230
| +3% | +$314K | 0.09% | 205 |
|
|
2025
Q3 | $11.6M | Buy |
121,441
+26,565
| +28% | +$2.44M | 0.09% | 200 |
|
|
2025
Q2 | $8.27M | Buy |
94,876
+3,856
| +4% | +$327K | 0.07% | 269 |
|
|
2025
Q1 | $8.18M | Buy |
91,020
+14,610
| +19% | +$1.31M | 0.08% | 242 |
|
|
2024
Q4 | $6.1M | Buy |
76,410
+3,182
| +4% | +$275K | 0.06% | 283 |
|
|
2024
Q3 | $6.59M | Buy |
73,228
+2,298
| +3% | +$193K | 0.07% | 282 |
|
|
2024
Q2 | $5.58M | Buy |
70,930
+1,896
| +3% | +$155K | 0.06% | 288 |
|
|
2024
Q1 | $6.02M | Buy |
69,034
+8,352
| +14% | +$713K | 0.06% | 289 |
|
|
2023
Q4 | $5.25M | Sell |
60,682
-19,838
| -25% | -$1.51M | 0.06% | 299 |
|
|
2023
Q3 | $6.31M | Sell |
80,520
-4,667
| -5% | -$391K | 0.08% | 252 |
|
|
2023
Q2 | $7.5M | Sell |
85,187
-181
| -0.2% | -$15.6K | 0.08% | 243 |
|
|
2023
Q1 | $6.88M | Buy |
85,368
+45,125
| +112% | +$3.68M | 0.08% | 208 |
|
|
2022
Q4 | $3.13M | Buy |
40,243
+2,535
| +7% | +$205K | 0.06% | 313 |
|
|
2022
Q3 | $3.04M | Buy |
37,708
+5,137
| +16% | +$462K | 0.06% | 297 |
|
|
2022
Q2 | $2.92M | Sell |
32,571
-41,343
| -56% | -$4.19M | 0.06% | 333 |
|
|
2022
Q1 | $8.2M | Sell |
73,914
-34,930
| -32% | -$3.69M | 0.13% | 159 |
|
|
2021
Q4 | $11.3M | Sell |
108,844
-9,649
| -8% | -$1.12M | 0.16% | 135 |
|
|
2021
Q3 | $14.7M | Sell |
118,493
-94
| -0.1% | -$12.2K | 0.23% | 97 |
|
|
2021
Q2 | $14.7M | Buy |
118,587
+713
| +0.6% | +$89.5K | 0.2% | 122 |
|
|
2021
Q1 | $13.9M | Buy |
117,874
+72,519
| +160% | +$8.5M | 0.21% | 116 |
|
|
2020
Q4 | $5.32M | Sell |
45,355
-55,672
| -55% | -$6.13M | 0.08% | 290 |
|
|
2020
Q3 | $10.5M | Buy |
101,027
+93,576
| +1,256% | +$9.4M | 0.18% | 136 |
|
|
2020
Q2 | $683K | Buy |
+7,451
| New | +$714K | 0.03% | 230 |
|
|
2020
Q1 | – | Sell |
-346
| Closed | -$39K | – | 566 |
|
|
2019
Q4 | $39K | Buy |
346
+106
| +44% | +$11.6K | ﹤0.01% | 443 |
|
|
2019
Q3 | $26K | Sell |
240
-2,544
| -91% | -$265K | ﹤0.01% | 484 |
|
|
2019
Q2 | $271K | Buy |
2,784
+1,966
| +240% | +$180K | 0.01% | 345 |
|
|
2019
Q1 | $75K | Buy |
818
+625
| +324% | +$55.9K | ﹤0.01% | 411 |
|
|
2018
Q4 | $18K | Hold |
193
| – | – | ﹤0.01% | 451 |
|
|
2018
Q3 | $19K | Buy |
193
+68
| +54% | +$6.29K | ﹤0.01% | 437 |
|
|
2018
Q2 | $11K | Buy |
125
+78
| +166% | +$6.51K | ﹤0.01% | 484 |
|
|
2018
Q1 | $4K | Hold |
47
| – | – | ﹤0.01% | 490 |
|
|
2017
Q4 | $4K | Sell |
47
-53
| -53% | -$4.25K | ﹤0.01% | 479 |
|
|
2017
Q3 | $8K | Buy |
100
+53
| +113% | +$4.4K | ﹤0.01% | 455 |
|
|
2017
Q2 | $4K | Buy |
+47
| New | +$3.96K | ﹤0.01% | 443 |
|
|
2016
Q4 | – | Sell |
-55
| Closed | -$5K | – | 583 |
|
|
2016
Q3 | $5K | Buy |
+55
| New | +$4.79K | ﹤0.01% | 414 |
|
|
2016
Q1 | – | Sell |
-411
| Closed | -$32K | – | 580 |
|
|
2015
Q4 | $32K | Buy |
411
+11
| +3% | +$828 | ﹤0.01% | 345 |
|
|
2015
Q3 | $27K | Hold |
400
| – | – | ﹤0.01% | 337 |
|
|
2015
Q2 | $30K | Hold |
400
| – | – | ﹤0.01% | 328 |
|
|
2015
Q1 | $31K | Buy |
+400
| New | +$30.3K | ﹤0.01% | 322 |
|
|
2014
Q4 | – | Sell |
-400
| Closed | -$25K | – | 435 |
|
|
2014
Q3 | $25K | Hold |
400
| – | – | ﹤0.01% | 293 |
|
|
2014
Q2 | $26K | Hold |
400
| – | – | ﹤0.01% | 302 |
|
|
2014
Q1 | $25K | Buy |
+400
| New | +$23.3K | ﹤0.01% | 313 |
|
Other funds holding MDT
Brinker Capital Investments's MDT Position: Q2 2026 in Review
Brinker Capital Investments reduced its Medtronic (MDT) stake by 9.8% in Q2 2026, selling an estimated $795K and leaving 90,220 shares worth $7.06M. The position accounts for 0.05% of the portfolio, ranked #308.
Brinker Capital Investments first reported a position in MDT in Q1 2014 and has held it in 44 quarters since. The position peaked at $14.7M in Q2 2021. 2,131 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Brinker Capital Investments held 90,220 shares of Medtronic worth $7.06M as of Q2 2026.
- Brinker Capital Investments sold 9,854 Medtronic shares in Q2 2026, an estimated $795K.
- Medtronic made up 0.05% of Brinker Capital Investments's portfolio in Q2 2026, its #308 holding.
- Brinker Capital Investments first reported a position in Medtronic in Q1 2014 and has held it in 44 quarters since.
- Brinker Capital Investments's Medtronic position peaked at $14.7M in Q2 2021.
- 2,131 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.